Daniel Weintraub
- Association of Dopamine Agonist Use With Impulse Control Disorders in Parkinson Disease
2006/07/01 by Daniel Weintraub, Andrew Siderowf, Andrew D. Siderowf +7 · 27 citations
Medicine · #Parkinson's Disease Mechanisms and Treatments #Restless Legs Syndrome Research #Neurological disorders and treatments
- CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease
2015/09/01 by Mark Terrelonge, Karen S. Marder, Karen Marder +2 · 3 citations
Medicine · #Alzheimer's disease research and treatments #Dementia and Cognitive Impairment Research #Parkinson's Disease Mechanisms and Treatments
- Task force report: Scales for screening and evaluating tremor: Critique and recommendations
2013/09/03 by Rodger Elble, Rodger J. Elble, Peter G. Bain +15 · 2 citations
Medicine · #Neurological disorders and treatments #Botulinum Toxin and Related Neurological Disorders #Parkinson's Disease Mechanisms and Treatments
- Ambient Air Pollution and the Severity of Alzheimer Disease Neuropathology
2025/09/08 by Boram Kim, Kaitlin Blam, Holly Elser +10 · 1 voice · 6 citations
Environmental Science · #Air Quality and Health Impacts #Heavy Metal Exposure and Toxicity #Health, Environment, Cognitive Aging
- Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease
2011/11/21 by Daniel Weintraub, D. Weintraub, N. Dietz +15 · 25 citations
Medicine · #Parkinson's Disease Mechanisms and Treatments #Alzheimer's disease research and treatments #Dementia and Cognitive Impairment Research
- Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease
2016/04/12 by David R. Roalf, David R Roalf, Tyler M Moore +22 · 1 citation
Medicine · Neuroscience · #Dementia and Cognitive Impairment Research #Traumatic Brain Injury Research #Functional Brain Connectivity Studies